Vericel Corp. (VCEL)
38.54
+1.16
(+3.10%)
USD |
NASDAQ |
Jun 11, 14:26
Vericel Price : 38.54 for June 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 37.01 | 38.17 | 36.90 | 37.38 | 617751.0 |
| Jun 09, 2026 | 36.67 | 37.71 | 36.43 | 37.03 | 628277.0 |
| Jun 08, 2026 | 36.38 | 37.27 | 35.72 | 35.77 | 371975.0 |
| Jun 05, 2026 | 35.73 | 36.91 | 35.73 | 36.30 | 558317.0 |
| Jun 04, 2026 | 35.45 | 36.86 | 35.38 | 35.69 | 707278.0 |
| Jun 03, 2026 | 34.43 | 35.92 | 34.02 | 34.74 | 599631.0 |
| Jun 02, 2026 | 32.46 | 35.20 | 32.01 | 34.45 | 940742.0 |
| Jun 01, 2026 | 32.93 | 33.97 | 32.14 | 32.82 | 530058.0 |
| May 29, 2026 | 34.25 | 34.29 | 33.24 | 33.33 | 480629.0 |
| May 28, 2026 | 34.21 | 34.81 | 33.67 | 34.24 | 397010.0 |
| May 27, 2026 | 35.05 | 35.55 | 33.64 | 34.27 | 448879.0 |
| May 26, 2026 | 34.80 | 35.42 | 34.44 | 34.97 | 465457.0 |
| May 22, 2026 | 35.24 | 35.47 | 34.68 | 34.73 | 383595.0 |
| May 21, 2026 | 34.99 | 36.35 | 34.63 | 35.15 | 1.072M |
| May 20, 2026 | 34.59 | 35.72 | 34.15 | 35.40 | 634039.0 |
| May 19, 2026 | 35.08 | 35.61 | 34.36 | 34.49 | 565650.0 |
| May 18, 2026 | 33.03 | 35.06 | 33.03 | 34.87 | 524335.0 |
| May 15, 2026 | 32.79 | 33.38 | 32.25 | 33.03 | 448985.0 |
| May 14, 2026 | 33.03 | 33.92 | 32.58 | 33.14 | 453206.0 |
| May 13, 2026 | 32.57 | 33.45 | 32.01 | 32.84 | 730437.0 |
| May 12, 2026 | 33.13 | 33.76 | 32.71 | 32.94 | 486683.0 |
| May 11, 2026 | 32.99 | 33.91 | 32.10 | 32.92 | 827670.0 |
| May 08, 2026 | 34.74 | 34.74 | 31.86 | 33.46 | 1.542M |
| May 07, 2026 | 40.50 | 40.85 | 34.52 | 35.13 | 1.193M |
| May 06, 2026 | 37.59 | 38.09 | 36.37 | 36.78 | 828658.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Marker Therapeutics, Inc. | 1.38 |
| Krystal Biotech, Inc. | 322.24 |
| TG Therapeutics, Inc. | 47.90 |
| Gyre Therapeutics, Inc. | 6.13 |
| ACADIA Pharmaceuticals, Inc. | 21.46 |
Price Related Metrics
| PE Ratio | 94.21 |
| PS Ratio | 6.766 |
| PEG Ratio | 0.1004 |
| Price to Book Value | 5.519 |
| Price to Free Cash Flow | 41.62 |
| Earnings Yield | 1.06% |
| Market Cap | 1.966B |
| PEGY Ratio | 0.1004 |
| Operating PE Ratio | 125.31 |
| Normalized PE Ratio | 94.23 |